Healthcare · NIFTY 500

Global Health Limited

NSEMEDANTA BSE543654 ISININE474Q01031 SeriesEQ Listed on NSE · BSE

₹1,439.90 +10.90 (+0.76%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close+11.26% in a year

Today

Open: ₹1,435.90
Prev close: ₹1,429.00
Day high: ₹1,454.70
Day low: ₹1,431.30
Volume: 2.20 L
Value traded: ₹31.75 Cr
Upper circuit: ₹1,714.80
Lower circuit: ₹1,143.20
52W high: ₹1,544.00
52W low: ₹956.00
1 month: +8.89%
6 months: +12.17%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹38,687 Cr

P/E (TTM)62.66

P/B8.95

Book value / share₹160.92

EPS (TTM)₹22.98

ROE9.2%

Dividend yield0.03%

Dividend (12m)₹0.50 / share

Net margin (TTM)7.9%

Operating margin25.2%

Debt / equity0.16

Current ratio2.72

EV / EBITDA36.15

Sales growth (YoY qtr)+33.64%

Profit growth (YoY qtr)-100.00%

Sales CAGR 3Y+17.85%

Profit CAGR 3Y+19.50%

Shares26.87 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

833124

Dec 23

809127

Mar 24

861106

Jun 24

957131

Sep 24

943143

Dec 24

931101

Mar 25

1,031159

Jun 25

1,099158

Sep 25

1,12195.0

Dec 25

1,159144

Mar 26

1,304159

Jun 26

1,4690.0

Sep 26

Revenue · QoQ (vs last quarter)

—-2.9%+6.5%+11%-1.4%-1.3%+11%+6.6%+2.0%+3.4%+13%+13%

Revenue · YoY (vs a year ago)

————+13%+15%+20%+15%+19%+24%+27%+34%

Net profit · QoQ (vs last quarter)

—+3.0%-17%+23%+9.2%-29%+57%-0.4%-40%+52%+10%-100%

Net profit · YoY (vs a year ago)

————+16%-20%+50%+21%-34%+42%-0.2%-100%

RevenueNet profitLine = trend

4.60

Dec 23

4.74

Mar 24

3.96

Jun 24

4.87

Sep 24

5.32

Dec 24

3.77

Mar 25

5.91

Jun 25

5.89

Sep 25

3.54

Dec 25

5.34

Mar 26

5.90

Jun 26

8.20

Sep 26

EPS (₹) · YoY (vs a year ago)

————+16%-20%+49%+21%-33%+42%-0.2%+39%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	833	809	861	957	943	931	1,031	1,099	1,121	1,159	1,304	1,469
Other income	21.9	27.4	21.9	18.2	16.0	22.9	20.5	19.7	21.8	36.7	22.2	23.6
Total income	855	836	883	975	959	954	1,051	1,119	1,143	1,196	1,326	1,493
Raw material	172	177	188	204	207	191	213	227	227	216	257	279
Purchases	18.1	17.6	23.1	28.2	20.7	20.5	31.8	28.8	28.9	27.8	40.7	45.8
Employee cost	185	188	201	214	205	204	256	274	281	285	319	335
Other expenses	245	248	265	286	271	289	308	338	367	384	404	443
Total expenses	682	693	739	794	770	771	863	935	986	1,009	1,113	1,198
Operating profit	212	179	186	228	238	175	247	247	181	244	287	370
OPM %	25.5%	22.2%	21.6%	23.9%	25.2%	18.8%	23.9%	22.5%	16.1%	21.0%	22.0%	25.2%
Finance cost	17.7	18.2	18.0	16.0	16.3	15.0	13.8	17.1	21.5	26.7	26.7	28.1
Depreciation	44.0	45.5	46.6	49.4	48.4	49.3	45.1	49.7	61.2	66.5	69.0	70.8
Exceptional items	—	—	—	—	—	-49.9	19.6	16.0	-36.6	—	—	—
Profit before tax	172	143	144	181	189	133	208	200	120	187	213	295
Tax	48.8	15.7	37.4	50.3	46.2	32.1	49.2	41.4	24.8	45.6	56.0	75.7
Net profit	124	127	106	131	143	101	159	158	95.0	142	157	219
Profit to shareholders	124	127	106	—	143	101	159	158	95.0	144	159	0.0
EPS (₹)	4.60	4.74	3.96	4.87	5.32	3.77	5.91	5.89	3.54	5.34	5.90	8.20

Profit & loss

Results for each year

4 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

2,694612326

FY23

3,275799478

FY24

3,692827481

FY25

4,410918556

FY26

Revenue · YoY (vs a year ago)

—+22%+13%+19%

Net profit · YoY (vs a year ago)

—+47%+0.7%+16%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY23	FY24	FY25	FY26
Revenue	2,694	3,275	3,692	4,410
Other income	64.9	74.7	79.1	98.6
Total expenses	2,310	2,723	3,074	3,793
Employee cost	634	735	825	1,096
Operating profit	612	799	827	918
OPM %	22.7%	24.4%	22.4%	20.8%
Finance cost	77.9	73.9	65.3	79.1
Depreciation	150	173	194	223
Profit before tax	449	627	647	715
Tax	123	149	166	161
Tax rate %	27.4%	23.8%	25.6%	22.5%
Net profit	326	478	481	554
Profit to shareholders	—	478	481	556
Net margin %	12.1%	14.6%	13.0%	12.6%
EPS (₹)	12.57	17.80	17.92	20.66

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

2,428842767

Mar 23

2,906419425

Mar 24

3,386328230

Mar 25

3,9621,190127

Mar 26

4,323695296

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+20%+17%+17%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	2,428	2,906	3,386	3,962	4,323
Long-term borrowings	737	283	264	1,127	659
Short-term borrowings	105	136	63.8	63.0	36.1
Total borrowings	842	419	328	1,190	695
Current liabilities	573	618	619	627	768
Fixed assets (PPE)	1,708	1,813	1,975	3,779	3,937
Inventories	60.4	66.9	67.1	79.0	88.3
Trade receivables	194	215	292	411	522
Cash & equivalents	767	425	230	127	296
Current assets	1,579	1,509	1,533	1,675	2,089
Total assets	4,116	4,304	4,766	5,905	6,606
Debt / equity	0.35	0.14	0.10	0.30	0.16

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

645-342346

FY23

612-441-514

FY24

624-721-97.2

FY25

714-1,065248

FY26

Operations · YoY (vs a year ago)

—-5.0%+1.9%+15%

OperationsInvestingFinancingLine = trend

₹ Cr	FY23	FY24	FY25	FY26
Cash from operations	645	612	624	714
Cash from investing	-342	-441	-721	-1,065
Cash from financing	346	-514	-97.2	248
Spent on fixed assets	-236	-279	-517	-838
Free cash flow	409	334	107	-124
Net cash flow	648	-343	-194	-103

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

33.1%Dec 23

33.0%Mar 24

33.0%Jun 24

33.0%Sep 24

33.0%Dec 24

33.0%Mar 25

33.0%Jun 25

33.0%Sep 25

33.0%Dec 25

33.0%Mar 26

33.0%Jun 26

33.0%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

33.0%promoter

Promoter & group: 33.00%
Public (FIIs, mutual funds, retail…): 66.88%
Employee trusts: 0.12%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Re 0.50 Per ShareEx 14-Aug-2026
Dividend - Re 0.50 Per ShareEx 22-Aug-2025

Board meetings

GLOBAL HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financ…03-Nov-2026
the financial results for the period ended September 30, 202603-Nov-2026
Global Health Limited has informed the Exchange about Board Meeting to be held on 30-Jul-2026 to inter-alia consider and approve the Unaudited Financ…30-Jul-2026
the financial results for the period ended Jun 30, 202630-Jul-2026
the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend, if any subject to shareholders approval.14-May-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates4 Nov
Copy of Newspaper Publication4 Nov

Latest news

Global Health Share Price Today: Up 2.59% at Rs 1,292.65Univest · 28 Oct, 12:30 pm Global Health Ltd. Share Price Today - Global Health Ltd. Stock Price Live NSE/BSECNBC TV18 · 3 Jan, 9:50 pm Total healthcare spending as a share of GDP, 2023Our World in Data · 22 May, 12:30 pm Health Financing in an Era of Eroding Global Health Solidarityorfonline.org · 3 Dec, 1:30 pm Transforming the Global Health Ecosystem for a Healthier World in 2026Think Global Health · 7 Jan, 1:30 pm Global Health Share Price Fall: Medanta Valuation ViewUnivest · 22 Oct, 12:30 pm MEDANTA Share Price Today - Global Health Stock AnalysisEquitypandit · 8 Apr, 11:30 am Global Health Ltd. Share Price Today | Global Health Live NSE/BSEValue Research · 17 Nov, 4:57 pm

About

About Global Health Limited

Global Health Limited is listed on the NSE under the symbol MEDANTA and belongs to the Healthcare sector.

Company details

Company name: Global Health Limited
NSE symbol: MEDANTA
BSE scrip code: 543654
ISIN: INE474Q01031
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 16 Nov 2022
Face value: ₹2 per share
Market lot: 1 share
Shares issued: 26.87 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Hospital/Nursing Management
Managing director / CEO: Pankaj Sahni
Chair: Naresh Trehan
Headquarters: Gurgaon, IN
Registered address: “Medanta The Medicity”, Sector 38, Gurugram, Haryana 122001
Founded: 2004
Employees: 14,777
Financial year: April to March
Results basis: Consolidated
Website: medanta.org

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Global Health Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers